Patient‐reported outcomes and targeted therapeutic escalation in NRG Oncology/RTOG 1010: When intensification fails to translate to improved outcomes
Cancer · 15.08.2026 · 132 (16)
DOI: 10.1002/cncr.70576 ↗Kurz gefasst
Editorial in der Zeitschrift Cancer, online erschienen am 12.08.2026. Verfasst von Timothy J Brown und 3 weiteren Autor:innen. Beteiligte Einrichtung: Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In NRG Oncology/RTOG 1010, HER2‐targeted escalation did not improve survival or patient‐reported outcomes in localized esophageal adenocarcinoma. The study illustrates that biologic plausibility and metastatic success do not guarantee benefit in the curative‐intent setting and emphasizes the need for rigorous, patient‐centered end point design in future biomarker‐directed trials.
Autor:innen und Institutionen
- Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Northwell Health, New York, New York, USA.
- Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.
ORCID-Profile: Timothy J Brown, Nicholas J Hornstein, Nina N Sanford
Zitieren
APA
Brown, T. J., Hornstein, N. J., Grewal, U. S., & Sanford, N. N. (2026). Patient‐reported outcomes and targeted therapeutic escalation in NRG Oncology/RTOG 1010: When intensification fails to translate to improved outcomes. Cancer, 132(16). https://doi.org/10.1002/cncr.70576
Vancouver
Brown TJ, Hornstein NJ, Grewal US, Sanford NN. Patient‐reported outcomes and targeted therapeutic escalation in NRG Oncology/RTOG 1010: When intensification fails to translate to improved outcomes. Cancer. 2026;132(16). doi:10.1002/cncr.70576
BibTeX
@article{Brown2026,
author = {Brown, Timothy J and Hornstein, Nicholas J and Grewal, Udhayvir S and Sanford, Nina N},
title = {Patient‐reported outcomes and targeted therapeutic escalation in NRG Oncology/RTOG 1010: When intensification fails to translate to improved outcomes},
journal = {Cancer},
year = {2026},
volume = {132},
number = {16},
doi = {10.1002/cncr.70576}
}
EUVIMED